Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

A progressive disease of the central and autonomic nervous systems in which idiopathic orthostatic hypotension is a major feature. Other features include bladder and bowel incontinence, anhidrosis, iris atrophy, amyotrophy, ataxia and rigidity. It is known as a multiple system atrophy, which helps to distinguish it from syndromes of pure autonomic failure. More common in males.

Described in 1960 by G.M. Shy, an American Neurologist, and G.A. Drager, an American physician, in Houston, Texas.

Autosomal dominant.

Postmortem examination demonstrates degeneration of autonomic neurons in the intermediolateral columns, putamen, substantia nigra, locus ceruleus, inferior olivary nuclei, and degenerative change in peripheral ganglia. Loss of central sympathetic tone results in inability to vasoconstrict or to mount a tachycardia in response to posture changes causing hypotension. Involvement of the corticospinal, corticocerebellar, and pyramidal tracts later in the disease process gives rise to symptoms of parkinsonism.

A consensus statement generated by the American Autonomic Society and the American Academy of Neurology, defining the various neurogenic causes of autonomic dysfunction, suggested abandonment of the term `Shy-Drager' syndrome in 1996. A new classification for the autonomic disorders has been best summarized as follows: (1) primary or cause unknown, described as pure autonomic failure (previously called idiopathic orthostatic hypotension or the Bradbury-Eggleston syndrome) and in which no neurologic defects other than autonomic dysfunction are present; and (2) multiple system atrophy, a sporadic, progressive, adult-onset disorder characterized by autonomic dysfunction, parkinsonism, and ataxia in any combination. History, demonstration of postural hypotension, and special investigations to demonstrate sympathetic insufficiency. Must exclude all other possible causes of orthostatic hypotension. It usually ends in death 7 to 10 years after the onset of symptoms.

Symptoms include dizziness on rising, syncope, and anhydrosis. Sexual dysfunction, urinary incontinence, fecal incontinence, dysphagia, unequal pupils, atrophy of the iris, external ophthalmoplegia, and wasting of distal limb muscles all reflect the degenerative changes within the central nervous system and autonomic ganglia. Nocturnal polyuria and natriuresis are present early in the natural history of the Shy-Drager syndrome and cause relative hypovolemia and exacerbation of hypotension on rising from bed. Central sleep apnea has been demonstrated on rare occasions. Signs and symptoms of bradykinesia, rigidity, and tremor occur following a variable interval (ranging from weeks to years) after development of orthostatic hypotension. An abnormal response to the Valsalva maneuver is easily demonstrated. Special investigations include stress tests to show absent sympathetic response; demonstration of lack of response to atropine; assessment of ability to sweat; infusion of direct-acting sympathomimetic agents, which causes hypertension and tachycardia, in contrast to indirect-acting agents (e.g., ephedrine) that has a limited or no effect. The most useful treatment appears to be 9α-fludrocortisone and compression stockings along with elevation of the head of the bed when sleeping. Amphetamines, monoamine oxidase inhibitors (MAOIs), indomethacin, dihydroergotamine, and propranolol have all been used with varying success.

An anesthesiology consultation is highly recommended ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.